[go: up one dir, main page]

MX2021002529A - Analogos de illudin, usos de los mismos y metodos para sintetizar los mismos. - Google Patents

Analogos de illudin, usos de los mismos y metodos para sintetizar los mismos.

Info

Publication number
MX2021002529A
MX2021002529A MX2021002529A MX2021002529A MX2021002529A MX 2021002529 A MX2021002529 A MX 2021002529A MX 2021002529 A MX2021002529 A MX 2021002529A MX 2021002529 A MX2021002529 A MX 2021002529A MX 2021002529 A MX2021002529 A MX 2021002529A
Authority
MX
Mexico
Prior art keywords
illudin
methods
synthesizing
same
illudin analogs
Prior art date
Application number
MX2021002529A
Other languages
English (en)
Inventor
Gregory J Tobin
Andrey D Malakhov
Varsin A Archer
Shawn T Blumger
Original Assignee
Lantern Paharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lantern Paharma Inc filed Critical Lantern Paharma Inc
Publication of MX2021002529A publication Critical patent/MX2021002529A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/527—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings
    • C07C49/573—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings containing hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/10—Preparation of carboxylic acid amides from compounds not provided for in groups C07C231/02 - C07C231/08
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C07C231/24—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/18—Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/385—Saturated compounds containing a keto group being part of a ring
    • C07C49/487—Saturated compounds containing a keto group being part of a ring containing hydroxy groups
    • C07C49/507—Saturated compounds containing a keto group being part of a ring containing hydroxy groups polycyclic
    • C07C49/513—Saturated compounds containing a keto group being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/93—Spiro compounds
    • C07C2603/94—Spiro compounds containing "free" spiro atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención proporciona derivados de iludina, intermedios, métodos de preparación, composiciones farmacéuticas y usos de los mismos. Los ejemplos específicos incluyen nuevas rutas sintéticas para preparar derivados de iludina y un derivado de iludina que tiene una rotación óptica positiva que tiene valor terapéutico.
MX2021002529A 2018-09-04 2019-09-04 Analogos de illudin, usos de los mismos y metodos para sintetizar los mismos. MX2021002529A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862726914P 2018-09-04 2018-09-04
PCT/US2019/049555 WO2020051222A1 (en) 2018-09-04 2019-09-04 Illudin analogs, uses thereof, and methods for synthesizing the same

Publications (1)

Publication Number Publication Date
MX2021002529A true MX2021002529A (es) 2021-08-11

Family

ID=69722656

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021002529A MX2021002529A (es) 2018-09-04 2019-09-04 Analogos de illudin, usos de los mismos y metodos para sintetizar los mismos.

Country Status (10)

Country Link
US (2) US11739043B2 (es)
EP (1) EP3846791A4 (es)
JP (1) JP7489966B2 (es)
KR (1) KR20210087435A (es)
CN (1) CN112804995A (es)
AU (1) AU2019335222A1 (es)
BR (1) BR112021006710A2 (es)
CA (1) CA3111772A1 (es)
MX (1) MX2021002529A (es)
WO (1) WO2020051222A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11135182B2 (en) 2014-04-10 2021-10-05 Af Chemicals, Llc Affinity medicant conjugates
KR20210087435A (ko) * 2018-09-04 2021-07-12 랜턴 파마 인코포레이티드 일루딘 유사체, 이의 용도, 및 이의 합성 방법
US11160807B1 (en) 2018-12-11 2021-11-02 Af Chemicals, Llc Methods, compositions and devices for treating cancer with illudofulvenes
CN111269257A (zh) * 2020-03-16 2020-06-12 福建省微生物研究所 一种Marizomib关键中间体的制备方法及其应用
EP4058005B1 (en) * 2020-12-29 2025-01-01 Lantern Pharma Inc. Hydroxyureamethyl acylfulvene for use in treating rhabdoid tumors
CA3215236A1 (en) * 2021-04-12 2022-10-20 Aditya Kulkarni Method for treating lung cancer and non-small cell lung cancer
KR20240073856A (ko) * 2021-07-29 2024-05-27 랜턴 파마 인코포레이티드 스피로노락톤 및 아실풀벤의 조합을 이용한 암의 치료

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439936A (en) * 1989-10-03 1995-08-08 The Regents Of The University Of California Method of treating certain tumors using illudin analogs
ATE141802T1 (de) * 1989-10-03 1996-09-15 Univ California Illudin-analoge, verwendet als antitumormittel
US5932553A (en) * 1996-07-18 1999-08-03 The Regents Of The University Of California Illudin analogs useful as antitumor agents
US5723632A (en) * 1996-08-08 1998-03-03 Mgi Pharma, Inc. Total synthesis of antitumor acylfulvenes
JP4989648B2 (ja) * 2005-08-03 2012-08-01 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 抗癌剤として有用なイルジン類似体
WO2015157578A2 (en) * 2014-04-10 2015-10-15 Af Chemicals, Llc Affinity medicant conjugates
US10285955B2 (en) * 2014-04-10 2019-05-14 Af Chemicals, Llc Affinity medicant conjugate
US9725769B1 (en) * 2016-10-07 2017-08-08 Oncology Venture ApS Methods for predicting drug responsiveness in cancer patients
KR20210087435A (ko) * 2018-09-04 2021-07-12 랜턴 파마 인코포레이티드 일루딘 유사체, 이의 용도, 및 이의 합성 방법
US20210230662A1 (en) * 2018-10-14 2021-07-29 Lantern Pharma Inc. Methods for the Treatment of Solid Tumor Cancers Using Illudins and Biomarkers

Also Published As

Publication number Publication date
CN112804995A (zh) 2021-05-14
US20230399285A1 (en) 2023-12-14
EP3846791A1 (en) 2021-07-14
CA3111772A1 (en) 2020-03-12
JP2021536492A (ja) 2021-12-27
US20210198191A1 (en) 2021-07-01
US11739043B2 (en) 2023-08-29
BR112021006710A2 (pt) 2021-08-10
AU2019335222A1 (en) 2021-05-06
WO2020051222A1 (en) 2020-03-12
EP3846791A4 (en) 2022-06-08
KR20210087435A (ko) 2021-07-12
JP7489966B2 (ja) 2024-05-24

Similar Documents

Publication Publication Date Title
MX2021002529A (es) Analogos de illudin, usos de los mismos y metodos para sintetizar los mismos.
PH12021551065A1 (en) Fused ring compounds
PH12021500014A1 (en) Fused ring compounds
MX2021002978A (es) Lactamas biciclicas y metodos de uso de las mismas.
CR20220251A (es) Nuevos derivados de metilquinazolinona
PH12020500105A1 (en) Bicyclic ketone compounds and methods of use thereof
MX362383B (es) Moduladores de acido oxabiciclo[2.2.2] gpr120.
MX2016007128A (es) Compuestos del receptor 6 de quimiocina (ccr6).
EA202092829A1 (ru) Композиции тофацитиниба с контролируемым высвобождением
MX2015011932A (es) Moduladores de gpr120 de acido biciclo[2.2.2].
EA202090368A1 (ru) Соединения-ингибиторы рецептора лизофосфатидной кислоты 1 (lpar1)
EA201892515A1 (ru) Стероидные 6,7-бета-эпоксиды в качестве интермедиатов
PH12020550125A1 (en) Crystalline forms of 3-substituted 1,2,4-oxadiazole
MX2017011978A (es) Analogos deuterados de etifoxina, sus derivados y usos de estos.
MX2015011375A (es) Moduladores del receptor acoplado a proteina-g 120 (gpr120) de acido biciclo-[2.2.1].
CO2020001471A2 (es) Compuesto pentacíclico
EA033314B1 (ru) АНТИБАКТЕРИАЛЬНЫЕ АГЕНТЫ, СОДЕРЖАЩИЕ ПИРАЗИНО[2,3-b][1,4]ОКСАЗИН-3-ОН ИЛИ РОДСТВЕННУЮ КОЛЬЦЕВУЮ СИСТЕМУ
MX2023011687A (es) Formas y composiciones farmaceuticas de ivosidenib.
AU2018275686A1 (en) Precipitation resistant small molecule drug formulations
AU2016250265A8 (en) (S)-2&#39;-vinyl-abscisic acid derivatives
MX2018005376A (es) Derivados de azetidina para formacion de imágenes de tau.
MX2019001167A (es) Derivados sinteticos estables de poliribosilribitolfosfato resistentes a la hidrolisis como vacunas contra haemophilus influenzae tipo b.
MX2022006776A (es) Composiciones farmaceuticas oftalmicas.
SA521421375B1 (ar) عمليات بديلة لتحضير مركبات تيوبولايسن ومركبات وسيطة منها
MX2018010652A (es) Composiciones farmaceuticas.